Anti-platelet treatments in acute coronary syndrome: Simplified network meta-analysis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference8 articles.
1. Adjusted in direct comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes;Biondi-Zoccai;Int J Cardiol,2010
2. Ticagrelor–is there need for a new player in the antiplatelet-therapy field?;Schömig;N Engl J Med,2009
3. Network meta-analysis. Results can be summarised in a simple figure;Fadda;BMJ,2011
4. First-line treatments for hepatitis C;Messori;Aliment Pharmacol Ther,2011
5. Fadda V, Maratea D, Trippoli S, Messori A. Treatments for macular degeneration: summarising evidence using network meta-analysis British Journal of Ophthalmology 2011 (in press).
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The mortality benefit seen with the newer more potent oral P2Y12 inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis;Cor et Vasa;2018-04-01
2. One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database;American Journal of Cardiovascular Drugs;2017-12-08
3. One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel;American Journal of Cardiovascular Drugs;2015-09-10
4. Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor;Journal of Medical Economics;2015-07-10
5. Prasugrel (Efient (R)) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis;HEALTH TECHNOL ASSES;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3